Quentis
New York, US · Founded 2015 · Delaware corporation · 3 known investors
Founders & leadership
JP
Joseph P. Vacca, Ph.DPresident and Treasurer
BF
B. Finn PeterSecretary
Board
MF
Michael Foley, Ph.D.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$22.7M disclosed across 2 rounds · 2016–2018
▶$19.7MraisedMar 2018 · 16 investors · BiotechnologyRule 506(b)
▶$19.7MraisedMar 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amy SchulmanDirector
- Michael FoleyDirector
- Michael AbermanExecutive Officer, Director
- Carlo RizzutoExecutive Officer, Director
- Offering amount
- $47.9M
- Amount sold
- $19.7M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3MraisedJun 2016 · 4 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph P. Vacca, Ph.DExecutive Officer
- B. Finn PeterExecutive Officer
- Michael Foley, Ph.D.Director
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $12.5K
- Proceeds to insiders
- $150K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Quentis's investors?
- Quentis's investors include Alexandria, Taiho Ventures, LLC, Versant Ventures.
- How much funding has Quentis raised?
- Quentis has disclosed $22.7M raised across 2 rounds.
- Where is Quentis headquartered?
- Quentis is headquartered in New York, US.